SYN-BAC - The first selenium nanoparticle-based antimicrobial dressing for treatment of MRSA infections in skin wounds

TECHNOLOGY SUMMARY

Selenium-based nanoparticle (SeNP) treatment for preventive and therapeutic use against bacteria. Our product, SYN-BAC, uses bacteria to produce corresponding therapeutic SeNPs with the aim of using them as antimicrobials towards the same bacteria that produce them. This approach is analogous to a Nanometric Trojan Horse to treating bacterial infections.

AREA/MATURITY/AWARDS

Primary Application Area: Biotech, Pharma, Health

Technology Development Status: Concept

Technology Readiness Level: TRL 3

SHOWCASE SUMMARY

Organization Type: Early-stage Startup (Seed)

Website: https://syncellbiotechnology.com

National Innovation Awardee

MARKET KEYWORDS

Market Keywords: Wound Dressing, Wound Healing, Targeted Anti-infective